Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Transplant. Feb 24, 2017; 7(1): 49-56
Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.49
Figure 1
Figure 1 Calculated major advance cardiac event risk score in the 242 renal transplant recipients and in the two groups. MACE score for all the RTRs, group A, defined as RTRs without MACE and group B, defined as RTRs with MACE, is respectively 14.6% ± 12.5%, 13.3% ± 11.1% and 22.3% ± 17.1%. MACE: Major advance cardiac event; RTRs: Renal transplant recipients.